U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07553442) titled 'A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran' on April 22.
Brief Summary: The purpose of this study is to evaluate the efficacy, pharmacodynamics (PD), and safety of ALN-AGT01 RVR in participants with mild to moderate hypertension pretreated with zilebesiran.
Study Start Date: April 27
Study Type: INTERVENTIONAL
Condition:
Hypertension
Intervention:
DRUG: ALN-AGT01 RVR
ALN-AGT01 RVR will be administered subcutaneously (SC)
DRUG: Placebo
Placebo will be administered SC
DRUG: Zilebesiran
Zilebesiran will be administered SC
Recruitment Status: NOT_YET_RE...